Get the Stockscreener App
13.91
0.71%
-0.0901
Tandem Diabetes Care Inc stock is traded at $13.91, with a volume of 853.90K.
It is down -0.71% in the last 24 hours and down -5.51% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$14.00
Open:
$14.17
24h Volume:
853.90K
Relative Volume:
0.41
Market Cap:
$940.23M
Revenue:
$796.00M
Net Income/Loss:
$-136.49M
P/E Ratio:
-6.6555
EPS:
-2.09
Net Cash Flow:
$-64.24M
1W Performance:
-6.96%
1M Performance:
-5.51%
6M Performance:
-35.29%
1Y Performance:
-56.44%
1-Day Range:
$13.69
$14.27
1-Week Range:
$13.66
$15.51
52-Week Range:
$9.98
$38.28
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
13.91 | 945.97M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
123.56 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.97 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.79 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.89 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.96 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Resumed | Stifel | Hold |
| Sep-08-25 | Initiated | Oppenheimer | Outperform |
| Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
| Jun-16-25 | Initiated | Truist | Hold |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Earnings visualization tools for Tandem Diabetes Care Inc.2025 Price Targets & AI Forecast Swing Trade Picks - newser.com
Chart overlay techniques for tracking Tandem Diabetes Care Inc.July 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Pattern recognition hints at Tandem Diabetes Care Inc. upsideWeekly Risk Report & Risk Controlled Daily Plans - newser.com
What indicators show strength in Tandem Diabetes Care Inc.Earnings Growth Report & Entry Point Strategy Guides - newser.com
Is Tandem Diabetes Care Inc. stock supported by innovation pipelineRisk Management & Verified Technical Signals - newser.com
Why Analysts Are Rethinking the Story Behind Tandem Diabetes Care After Recent Developments - Yahoo Finance
How Tandem Diabetes Care Inc. stock compares to industry benchmarksRate Hike & Verified Chart Pattern Signals - newser.com
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ... - Bluefield Daily Telegraph
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Real time pattern detection on Tandem Diabetes Care Inc. stockSwing Trade & Technical Pattern Based Buy Signals - newser.com
Tandem Diabetes Care (TNDM): Examining the Valuation After a Challenging Year and Recent Rebound - Sahm
Is Tandem Diabetes Care Inc. stock a buy on dipsPortfolio Return Report & Smart Allocation Stock Tips - newser.com
Will Tandem Diabetes Care Inc. (TD5A) stock outperform value peersEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Combining machine learning predictions for Tandem Diabetes Care Inc.Trade Ideas & Real-Time Price Movement Reports - newser.com
Using data models to predict Tandem Diabetes Care Inc. stock movementWeekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
How supply chain issues affect Tandem Diabetes Care Inc. stock2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
Tandem Diabetes Care announces upcoming conference presentations - MarketScreener
Tandem Diabetes Stock Falls on DexCom ForecastMarket Update 2025News and Statistics - IndexBox
Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today - Yahoo Finance
Tandem Diabetes Care Announces Upcoming Conference Presentations - Yahoo Finance
Is Tandem Diabetes Care Inc. (TD5A) stock a contrarian opportunityTrade Exit Summary & Low Risk High Win Rate Picks - newser.com
Can you recover from losses in Tandem Diabetes Care Inc.2025 Retail Activity & Safe Capital Growth Tips - newser.com
Is Tandem Diabetes Care Inc. still worth holding after the dipPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Will Tandem Diabetes Care Inc. stock recover after recent dropJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
Can Tandem Diabetes Care Inc. stock hit analyst price targetsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Why Tandem Diabetes Care Inc. stock is recommended by analystsQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Tandem Diabetes Care Launches t:slim X2 Pump Integration with Abbott FreeStyle Libre 3 Plus Sensor - HIT Consultant
Using R and stats models for Tandem Diabetes Care Inc. forecastingPortfolio Return Report & Stepwise Swing Trade Plans - newser.com
Market Might Still Lack Some Conviction On Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Even After 26% Share Price Boost - simplywall.st
Tandem Rolls Out t:slim X2 Insulin Pump with Abbott’s FreeStyle Libre 3 Plus - Medical Product Outsourcing
t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States - Business Wire
Implantable Insulin Pumps Market Size reached US$ 3.2 Billion - openPR.com
Will Tandem Diabetes Care Inc. (TD5A) stock outperform benchmarksPortfolio Value Summary & Free Verified High Yield Trade Plans - fcp.pa.gov.br
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):